Mouse Anti-Mouse VEGFR-3/FLT-4, Antagonistic
Slide this table
| Cat-Nr. | mV1003m-m |
| Size | 100 µg |
| Price | 625 € |
| Category | Monoclonal Antibody |
| Clone Nr. | (#9G03) |
| Isotype | IgG1 |
| Species Reactivity | Mouse |
| Formulation | lyophilized |
| Buffer | PBS |
| Reconstitution | Centrifuge the vial prior to opening. Reconstitute the antibody with 200 µl sterile PBS and the final concentration is 500 µg/ml. |
| Stability and Storage | Lyophilized samples are stable for 2 years from date of receipt when stored at -20°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity. |
| Preparation | This antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse) immunized with mouse VEGFR3 N-terminal recombinant protein. |
| Antigen | recombinant mouse VEGFR3 N-terminal protein |
| Application | Blocking VEGF-C induced activiation |
| Synonyms | vascular endothelial growth factor receptor-3; Flt4; Chy; Flt-4; VEGFR3; VEGFR-3 |
| Description | VEGFR-3, also known as FLT4, is a member of the Tyr protein kinase family. The extracellular portion of VEGFR-3 contains 7 immunoglobulin (Ig)-like domains and the cytoplasmic portion contains a protein kinase domain. FLT4 regulates angiogenesis and lymphangiogenesis, its ligands are VEGF-C and D and its binding is mediated by the 2nd and 3rd Ig-like domains of FLT4. During fetal development VEGFR-3 is expressed on endothelial cells, however, in the adult mice, the vascular endothelial cells lose VEGFR-3 expression, but the lymphatic endothelium expresses it constitutively. In addition, VEGFR-3 expression can be induced in tumors with active angiogenesis. |
| Uniprot ID | P35917 |
| Protein RefSeq | NP_032055.1 |
| mRNA RefSeq | NM_008029 |
All prices plus VAT + possible delivery charges